Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $41.50 USD
Change Today 0.00 / 0.00%
Volume 410.9K
WX On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for wuxi pharmatech cayman-adr (WX)

Year over year, WuXi PharmaTech (Cayman) Inc. has seen little change in their bottom line (from $114.6M USD to $112.2M USD) despite revenues that grew from $578.1M USD to $674.3M USD. A key factor has been an increase in the percentage of sales devoted to SGA costs from 16.50% to 18.81%.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues407.2499.9578.1674.3
TOTAL REVENUES407.2499.9578.1674.3
Cost of Goods Sold250.7316.7366.5422.5
GROSS PROFIT156.4183.2211.6251.7
Selling General & Admin Expenses, Total67.285.795.4126.8
R&D Expenses5.48.111.021.2
OTHER OPERATING EXPENSES, TOTAL72.693.8106.3148.0
OPERATING INCOME83.889.4105.2103.7
Interest Expense-0.8-1.7-2.0-2.6
Interest and Investment Income6.17.711.532.0
NET INTEREST EXPENSE5.36.09.529.4
Currency Exchange Gains (Loss)4.75.319.3-9.3
Other Non-Operating Income (Expenses)3.83.88.012.7
EBT, EXCLUDING UNUSUAL ITEMS97.6104.6142.1136.6
Impairment of Goodwill---1.7----
Gain (Loss) on Sale of Investments---0.6-4.0--
Other Unusual Items, Total--1.6----
Other Unusual Items--3.4----
EBT, INCLUDING UNUSUAL ITEMS97.6104.0138.0136.6
Income Tax Expense16.617.423.524.5
Earnings from Continuing Operations81.086.6114.6112.2
NET INCOME81.086.6114.6112.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS81.086.6114.6112.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS81.086.6114.6112.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WX:US $41.50 USD 0.00

WX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Charles River Laboratories International Inc $77.62 USD +3.18
Ergomed PLC 180.00 GBp 0.00
Hangzhou Tigermed Consulting Co Ltd CNY34.02 CNY -1.64
ICON PLC $80.80 USD -0.06
PAREXEL International Corp $68.96 USD +0.28
View Industry Companies
 

Industry Analysis

WX

Industry Average

Valuation WX Industry Range
Price/Earnings 26.5x
Price/Sales 4.1x
Price/Book 3.7x
Price/Cash Flow 26.2x
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WUXI PHARMATECH CAYMAN-ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.